Margaret Littlejohn
Board Member
Melbourne, Australia
Dr Margaret Littlejohn is a senior medical scientist at the Victorian Infectious Diseases Reference Laboratory, and Honorary Fellow in the Department of Infectious Diseases, based at the Peter Doherty Institute for Infection and Immunity at the University of Melbourne. She is an expert in HBV molecular virology and the role of HBV genotypes in pathogenesis and treatment response and is currently leading a project to develop a new RNA-based therapy for chronic hepatitis B, using CRISPR technology.
She is also involved in a long term collaboration examining the molecular epidemiology of HBV in Indigenous Australian populations, discovering a unique HBV sub-genotype found exclusively in the Indigenous Australian population. As a member of the WHO Collaborating Centre for Viral Hepatitis at VIDRL, she has been involved in missions to Mongolia and China as a technical consultant and is a member of the ICTV Hepadnaviridae Study Group.